| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 01/08/2009 | US20090012070 Pesticidal heterocycles |
| 01/08/2009 | US20090009061 Composition for Conductive Materials Comprising Crosslinkable Arylamine Compounds and Use Thereof in Electronic Devices and Electronic Equipment |
| 01/08/2009 | CA2692265A1 Amide compounds |
| 01/07/2009 | EP2011788A1 Oxadiazolidinedione compound |
| 01/07/2009 | CN101337944A P-38 kinase inhibitors |
| 01/07/2009 | CN100448853C Current carrier transmtiting material with high-effect and balancing electronic cavity transmitting performance |
| 01/01/2009 | US20090005427 Substituted oxadiazole compounds and their use as opioid receptor ligands |
| 12/31/2008 | EP2007705A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
| 12/31/2008 | CN100447137C P-38 kinase inhibitors |
| 12/25/2008 | US20080319030 Sydnonimines - specific dopamine reuptake inhibitors and their use in treating dopamine related disorders |
| 12/25/2008 | US20080318976 Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists |
| 12/25/2008 | US20080318255 Fluorescent Labeled Sphingosines |
| 12/24/2008 | WO2008157407A2 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia |
| 12/24/2008 | EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 12/24/2008 | CN100445272C Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity |
| 12/24/2008 | CN100445271C Amide derivative |
| 12/23/2008 | US7468393 Diarylsulfones as 5-HT2A antagonists |
| 12/23/2008 | US7468212 Organic electroluminescent device |
| 12/23/2008 | CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/23/2008 | CA2238427C Production method of aminobenzene compound |
| 12/18/2008 | WO2008152149A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists |
| 12/18/2008 | WO2008115259A3 Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases |
| 12/18/2008 | US20080312220 Oxadiazole Derivatives with Crth2 Receptor Activity |
| 12/18/2008 | CA2693126A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists |
| 12/17/2008 | CN101326155A Propionamide compounds as antiinflammatory agents |
| 12/16/2008 | US7465748 Amide derivative |
| 12/11/2008 | US20080306258 Cyclopropane compounds and pharmaceutical use thereof |
| 12/11/2008 | US20080306125 nuclear receptor modulators such as 6-{4-[3-(2,6-Dichloro-phenyl)-5-isopropyl-isoxazol-4-ylmethoxy]-phenyl}-1-isopropyl-1H-indole-3-carboxylic acid, used for treating dyslipidemia, atherosclerosis, diabetes, raising plasma high density lipoproteins, lowering low density lipoproteins and triglycerides |
| 12/11/2008 | US20080306124 Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands |
| 12/11/2008 | US20080306067 Modulators of Chemokine Receptor Activity |
| 12/11/2008 | US20080306041 Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use |
| 12/10/2008 | EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications |
| 12/09/2008 | US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds |
| 12/03/2008 | EP1997814A1 Functionalized Metal Nanoparticle, Buffer Layer Including the Same and Electronic Device Including the Buffer Layer |
| 12/03/2008 | CN101316829A Oxadiazole derivatives with crth2 receptor activity |
| 12/03/2008 | CN100439368C Organic eurepium compound based on functional o-phenan throline ligand and its electroluminous device |
| 12/03/2008 | CN100439329C 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 12/02/2008 | US7459566 1,2,4-oxadiazol-5-one-4-(benzimidazolylmethylamino)benzamidine compounds |
| 12/02/2008 | US7459472 Aryl and heteroaryl compounds, compositions, and methods of use |
| 12/02/2008 | CA2305548C Prostaglandin agonists and their use to treat bone disorders |
| 11/27/2008 | WO2008024303A3 Compounds for treating proliferative disorders |
| 11/27/2008 | WO2008013963A3 Fatty acid amide hydrolase inhibitors |
| 11/27/2008 | US20080293781 Salicylic Acid Derivatives |
| 11/27/2008 | US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands |
| 11/27/2008 | US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses |
| 11/27/2008 | US20080293702 Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use |
| 11/27/2008 | US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors |
| 11/27/2008 | US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use |
| 11/27/2008 | CA2685858A1 Di-substituted amides for enhancing glutamatergic synaptic responses |
| 11/25/2008 | US7456200 Compounds |
| 11/20/2008 | US20080287407 Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use |
| 11/19/2008 | EP1991535A1 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists |
| 11/18/2008 | US7452996 Substituted quinoline derivatives |
| 11/18/2008 | US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 11/13/2008 | WO2008135447A1 Acetamide derivatives as potassium channel modulators |
| 11/13/2008 | US20080280915 {1-[6-(trifluoromethyl)pyridin-3-yl]methyl}(methyl)- lambda 4-sulfanylidenecyanamide; especially useful for the control of aphids and other sucking insects |
| 11/13/2008 | US20080280876 Sphingosine-1-phosphate (S1P) receptor agonists or antagonists; immunosuppressants; e.g. 3-(3-chloro-4-isopropoxyphenyl)-5-(p-(3-carboxyazetidin-1-ylmethyl)phenyl)-1,2,4-oxadiazole; two specific compounds are excluded |
| 11/13/2008 | US20080280875 Fused phenyl amido heterocyclic compounds |
| 11/13/2008 | US20080280869 Therapy for diseases resulting from mutation of messenger Rna; suppression prenature translation termination; autoimmune diseases; blood disorders; collagen disease; diabetes; neurodegenerative diseases; cardiovascular disorders; central nervous system disorders; antiinflammatory agents |
| 11/12/2008 | EP1990338A2 Biphenylcyclopropylamides as p-38 Kinase inhibitors |
| 11/12/2008 | CN101304982A Process for the preparation of benzotriazepine derivatives |
| 11/06/2008 | WO2007098474A8 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists |
| 11/05/2008 | EP1987013A1 Bicyclic sphingosine 1-phosphate analogs |
| 11/05/2008 | EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases |
| 11/05/2008 | CN100430052C Cathepsin cysteine protease inhibitors |
| 10/30/2008 | WO2008130370A1 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression |
| 10/30/2008 | WO2008129319A1 Salts of oxadiazole derivatives as dgat inhibitors |
| 10/30/2008 | WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors |
| 10/30/2008 | WO2008107677A3 Thiadiazole and oxadiazole derivatives for the treatment of neurodegenerative disorders |
| 10/30/2008 | WO2008064320A3 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
| 10/30/2008 | US20080268014 Ethanamine, 2-L[5-oxido-4-phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]-N,N-bis[2-[[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]ethyl]-; cardiovascular diseases; inhibiting platelet aggregation, platelet adhesion caused by the exposure of blood to a medical device; abnormal cell proliferation |
| 10/29/2008 | EP1687284B1 p-38 KINASE INHIBITORS |
| 10/29/2008 | CN101296911A Arylurea derivatives as modulators of chemokine receptor activity |
| 10/28/2008 | US7442760 electroluminescent end capped polyarylenes, for use in electronics such as organic light emitting diodes, having high luminous efficiency and durability |
| 10/28/2008 | US7442702 Prostaglandin agonists |
| 10/28/2008 | US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 10/23/2008 | WO2008124878A1 Non-steroidal compounds |
| 10/23/2008 | WO2008021849A3 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 10/23/2008 | US20080262238 Dendron and Dendrimer, Method of Producing the Same, and Method of Producing a Thioacetal Compound |
| 10/23/2008 | US20080262052 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one |
| 10/23/2008 | US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 10/22/2008 | EP1981858A2 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti-inflammatory agents |
| 10/22/2008 | EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 10/22/2008 | EP1451276B1 1,3,4-oxadiazole additives for lubricants |
| 10/16/2008 | WO2008123349A1 Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative |
| 10/16/2008 | WO2008123207A1 Ornithine derivative |
| 10/16/2008 | WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 10/16/2008 | US20080255212 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one |
| 10/16/2008 | US20080255210 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system |
| 10/16/2008 | US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof |
| 10/16/2008 | US20080255182 Certain chemical entities, compositions, and methods |
| 10/16/2008 | US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread |
| 10/16/2008 | CA2681861A1 Ornithine derivative |
| 10/15/2008 | CN101287729A GPCR agonists |
| 10/15/2008 | CN100425599C Organic electroluminescent material and its application |
| 10/14/2008 | CA2309328C Cyclic amine derivatives and their use as drugs |
| 10/09/2008 | US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid |
| 10/08/2008 | EP1976838A1 Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative |
| 10/07/2008 | US7432293 Heterocyclic compounds useful as Nurr-1 activators |
| 10/07/2008 | US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |